Cargando…
Development of second primary small‐cell lung cancer within the irradiated field after chemoradiotherapy: a report of two cases
Two male smokers developed small‐cell lung cancer (SCLC) as the second primary malignancy (SPM) in the irradiated field after concurrent chemoradiotherapy for locally advanced cancer, which could also be considered as a radiation‐induced tumour. A 70‐year‐old man received cisplatin and S‐1 and irrad...
Autores principales: | Seike, Yuki, Kawagishi, Yukio, Bando, Akihito, Kimoto, Ko, Hongo, Masato, Takeda, Shinichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147749/ https://www.ncbi.nlm.nih.gov/pubmed/34094568 http://dx.doi.org/10.1002/rcr2.767 |
Ejemplares similares
-
Hyperprogressive Disease in Lung Cancer with Transformation of Adenocarcinoma to Small-cell Carcinoma during Pembrolizumab Therapy
por: Okeya, Komugi, et al.
Publicado: (2019) -
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
por: Zhang, Xiaoli, et al.
Publicado: (2014) -
Tangent field technique of TomoDirect improves dose distribution for whole‐breast irradiation
por: Hashimoto, Harumitsu, et al.
Publicado: (2015) -
Can involved-field irradiation replace elective nodal irradiation in chemoradiotherapy for esophageal cancer? A systematic review and meta-analysis
por: Wang, Xiaoyue, et al.
Publicado: (2017) -
Elective nodal irradiation versus involved-field irradiation in patients with esophageal cancer receiving neoadjuvant chemoradiotherapy: a network meta-analysis
por: Liu, Tingting, et al.
Publicado: (2019)